(Q55423406)

English

Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice. (English)

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

0 references

author name string

M Iigo

1

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

K Nishikata

2

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

Y Nakajima

3

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

M Moriyama

4

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

publication date

1 June 1989

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

80

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

6

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

554-561

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

A specific biosynthetic marker for immature thymic lymphoblasts. Active synthesis of thymus-leukemia antigen restricted to proliferating cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917796

9 July 2018

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917796

9 July 2018

Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917796

9 July 2018

Precursors of T cell growth factor producing cells in the thymus: ontogeny, frequency, and quantitative recovery in a subpopulation of phenotypically mature thymocytes defined by monoclonal antibody GK-1.5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917796

9 July 2018

Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917796

9 July 2018

Role of different T cells sets in the rejection of syngeneic chemically induced tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917796

9 July 2018

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1989.TB01675.X

21 January 2018

Functional identity between murine γ Interferon and macrophage activating factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1989.TB01675.X

21 January 2018

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4-/CD8-T cells: amplification in spleens of mice following in vivo treatment with monoclonal antibody anti-L3T4

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of helper T-lymphocytes in rejection of UV-induced murine skin cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. II. Lyt-1+2- T cells have potential to reject antigenically irrelevant (bystander) tumor cells on activation with the specific target tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2527216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.1989.TB01675.X

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 July 2018

http://europepmc.org/abstract/PMC/5917796

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55423406&oldid=1770218752"